Results 111 to 120 of about 7,979 (179)

10-Phenyl-9-[2-(tri-fluoro-meth-yl)phen-yl]-3,4,6,7,9,10-hexa-hydro-acridine-1,8(2<i>H</i>,5<i>H</i>)-dione. [PDF]

IUCrdata
Mominuddin M, Roy HN, Karmaker PG, Hossain MM, Zangrando E.   +4 more
europepmc   +1 more source

HeLa cells incubated with styryl compound C53

, 2008
This is part of a larger collection of archives of 1344 styryl compounds containing digital microscopic images of HeLa cells incubated with styryl compounds, along with other information about those compounds.
Rosania, Gustavo R., Shedden, Kerby A.
core  

Narrative review-the emerging role, functions, and mechanisms of UFMylation in cancers. [PDF]

Transl Cancer Res
Fang L, Yang F.
europepmc   +1 more source

Stock Returns Predictability in Transition Economies

stock return predictability, unobserved components, fat tails, stable distributions, C22, C53, G14,
Khurshid M. Kiani
core   +1 more source

Structural characterization of three norfloxacin salts with N-heterocyclic mono- and di-carb-oxy-lic acids. [PDF]

Acta Crystallogr E Crystallogr Commun
Ben A, Hushcha V, Chęcińska L.
europepmc   +1 more source

The adduct of di-μ₂-hydroxido-bis-[chlorido-di-phenyl-tin(IV)] with two mol-ecules of 2-vinyl-pyridine. [PDF]

Acta Crystallogr E Crystallogr Commun
Gieschen T, Reuter H.
europepmc   +1 more source

<i>N</i>-(3,5-Di-chloro-4-meth-oxy-phen-yl)acetamide. [PDF]

IUCrdata
Uppu RM, Bai SV, Mensah PF, Li G, Fronczek FR.   +4 more
europepmc   +1 more source

Characterization of a transmembrane-activating STING agonist using genetically humanized mice. [PDF]

Cell Rep
Mizuno N, Abraham J, Jimenez-Perez K, Rose I, Springgay L, Boehm D, Ando T, Streblow D, Ward J, Miller S, Pandey U, Junaid A, Joyner D, Muir R, Haddad EK, Burkhart D, Rasheed O, DeFilippis VR.   +17 more
europepmc   +1 more source

Synthesis and crystal structure of bis-[(1<i>E</i>,6<i>E</i>)-1,7-bis-(4-acet-yloxy-3-meth-oxy-phen-yl)hepta-1,6-diene-3,5-dionato(1-)-κ² <i>O</i>,<i>O</i>'](methanol)dioxidouranium(VI) toluene monosolvate. [PDF]

Acta Crystallogr E Crystallogr Commun
Nguyen VH, Trieu TN, Pham CT.
europepmc   +1 more source

C92, a proton channel-blocking allosteric STING agonist generates robust antitumor activity. [PDF]

J Immunother Cancer
Banerjee M, Middya SK, Shrivastava R, Middya A, Pryde DC, Chakraborty D, Soram T, Mane N, Rawat N, Gautam A, Puniya K, Sharma P, Yadav DB, Sônego F, Thiam K, Mills JE, Mani S, Ghosh R, Basu S, Surya A.   +19 more
europepmc   +1 more source